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1. Introduction With increasingly reﬁned genomic knowledge and technology,
whole-genome studies are becoming a mainstay of biomedical research. Examples include expression array experiments, comparative genomic hybridization analyses and
case-control studies for detecting single nucleotide polymorphism (SNP)/disease associations. Because of the large number of loci studied per subject and the resulting
numbers of statistics that are generated, statistical methods for controlling the number
of potentially spurious ﬁndings are needed. While the idea of controlling the False Discovery Rate (FDR)(Reiner et al, 2003; Storey and Tibshirani, 2003) or Positive False
Discovery Rate (pFDR)(Storey, 2002) has become popular, existing implimentations
of these methods might be inadequate for some purposes. For example, when used in
practice, the true FDR (or pFDR) is unknown and is replaced by an estimated proportion. Methods for estimating the FDR (or pFDR) are subject to varying degrees of bias
and variation (Pawitan et al, 2005; Broberg, 2005; Owen, 2005), and their behavior can
depend on the dependence stucture of the data. One popular pFDR method has been
shown to markedly underestimate the false discovery rate in the presence of a modest
number of true positives and modest correlation between test statistics (Yang et al,
2005). The development of conﬁdence intervals for FDR estimates in the presence of
correlated data will help alleviate this uncertainty. In the meantime, the Bonferroni
correction remains a reliable method for controlling the marginal false positive rate.
This method is employed in a multi-stage design to detect SNP-disease associations in
the Women’s Health Initiative (Prentice and QI, 2006). The well-known shortcoming
of the Bonferroni correction is that it is conservative, controlling the family-wise type
I error at lower than the nominal level, though the exact level of control is unknown.
The Bonferroni correction is least conservative when applied to uncorrelated test statistics. Moderate to high levels of correlation among some groups of test statistics can
be expected in most whole-genome studies. Potential statistical power is lost when this
correlation is ignored.
In this article, we show that regression methods for misspeciﬁed multivariate out2
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comes can be applied in whole-genome studies in order to gain power over methods that
model the outcome independently for each locus. (Note that regression for multivariate
outcomes should not be confused with the phrase “multivariate logistic regression” that
refers to a univariate outcome modeled as a function of more than one independent
variable. The phrase is commonly used in elementary biostatistics textbooks.) In situations such as a case-control study where the outcome usually is not regarded to be
multivariate (case versus control status), it is mathematically valid to view the outcome
as a set of (identical) repeated measurements, one associated with each genetic locus.
When applying multivariate outcome methods, it is common to regard all data collected
on one subject as a belonging to a single multivariate observation. Instead, we apply
multivariate methods to subgroups of outcome/covariate pairs. This represents an intermediate between determining a joint distribution for all test statistics and making
the assumption of independence among all statistics, with the latter being a special case
of the proposed method. We provide some guidelines on how to form these subgroups
below. In fact, most of the thousands of test statistics generated in genome-wide studies
can be expected to have negligible pair-wise correlations, and it is likely of little use to
estimate the entire joint distribution even if it were practically possible. For example,
in a SNP-disease association study, only test statistics for SNP locus pairs that are
close spatially or that are both related to the outcome are expected to be correlated.
Hence, eﬀective joint modeling of such SNPs within a relatively small subgroup (“cluster”) should provide much of the possible power gain that one could ideally obtain.
(For brevity, we use the terms “SNP” and “SNPs” to mean SNP locus and SNP loci,
respectively, where appropriate.)
Any multivariate estimation method that remains valid under misspeciﬁcation of
the correlation structure could be applied in the manner we describe, but we focus
here on the use of generalized estimating equations (GEE) for analysis of case-control
studies. GEE can provide power gains both by taking into account correlation during the
estimation procedure to produce smaller standard errors for single SNP test statistics
3
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and by producing an estimated joint distribution. However, it is believed that GEE is
not statistically appropriate for whole-genome studies because the number of outcomes
far exceeds the number of subjects. This belief is not true, in general. GEE and the
General Linear Model (GLM) comprise families of models with diﬀerent correlation
structures. Estimates obtained from these techniques will be valid in the setting of
many more outcomes than subjects as long as the modeled correlation between most
pairs of observations is weak and valid standard error estimates are used (c.f. Lumley
and Haegerty, 1999). For example, one particular formulation of GEE (with the identity
matrix as the working correlation matrix) is equivalent to performing logistic regression
for every SNP in a case-control study. By modeling only subgroups of data jointly, we
maintain conditions for valid estimation of test statistics.
In the rest of this paper, we provide a detailed description of how to implement the
proposed method using GEE software to analyze data from a case-control study of SNPdisease association. This description is intended to be accessible to non-statisticians.
We then report the design and results for a large simulation study of the method’s
operating characteristics and follow with discussion.
2. Methods In this section we describe how one can apply GEE with assumptions
of non-independence to increase statistical power over the application of independencebased logistic regression models to each SNP locus. We show how one may adjust
for confounding such as population structure, if desired. The utility of adjusting is
addressed in the Discussion. This section also describes the extensive simulation studies
performed for the method. For simplicity of presentation and analysis of the method’s
properties, we assume that the chosen genetic model assigns a score of either 0 or 1 to
each locus, and the goal is to ﬁnd loci for which the odds of disease is elevated when
the score is 1 relative to a score of 0. (No loss of generality for the qualitative results
of this article should occur by assuming this basic model, since more complex models
can be reduced to this case.) We assume that strong control of the family-wise Type I
error rate is desired.
4
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2.1 Modeling and Estimation with GEE To apply GEE, one chooses a model
for each locus-outcome pair that would be appropriate if that locus-outcome were the
only one studied. In practice, the same type of model is usually employed for all
locus/outcome pairs. For our case-control example, the outcome, Yi , for the ith subject
is either case or control status (Yi = 1 or 0, respectively). In both the independence
method applied by Prentice and QI (2006) and the non-independence method proposed
here, and a logistic model of the following form is assumed for each SNP score:
Prob[Yi = 1|Sji ] =

exp(αj + βj Sji )
1 + exp(αj + βj Sji )

(1)

where Sji is the genetic score at the j th SNP locus for the ith subject. Note that a
separate intercept, αj , and a separate association coeﬃcient, βj , is estimated for each
SNP locus. (This has practical implications for speciﬁcation of the design matrix when
ﬁtting the models in GEE (see below)).
Details regarding estimation in multivariate regression models under misspeciﬁed
correlation structure can be found in White (1982) and Gourieroux et al (1984) with
further extensions appearing as GEE in Liang and Zeger (1986). For the purposes of
this article, the two essential ingredients for increasing power are to (1) group correlated observations (within subject) into what are denoted as “clusters” in the statistical
literature; and (2) to choose a working correlation matrix structure that captures at
least part of the true correlation structure in the data. More speciﬁcally, for a cluster
of n correlated observations on subject i, the working correlation matrix, R, speciﬁes
the pair-wise correlations between the centered observations:
⎡
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1

where f is the logistic transformation used in model (1), given by f (x) = exp(x)/(1 +
exp(x)), the SNP loci assigned to this particular cluster have been numbered from S1 to
Sn, and R is a symmetric correlation matrix, so that rkl = rlk and |rjk | ≤ 1. Note that
5
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in our case-control example, Yij = Yik = Yi for all j and k since the case-control status
is ﬁxed for the ith subject. In the standard GEE modeling situation, observations in
diﬀerent clusters are assumed to be uncorrelated. Because designated clusters for this
method need not be independent under the true state of nature for the testing method
proposed here to be valid, we replace the term “cluster” with “subgroup” to avoid
confusion.
As shown in Gourieroux et al (1984), the correlation structure chosen for the estimation procedure need not be the true correlation structure in order for the estimation
to be valid, as long as “robust” standard errors of the coeﬃcient estimates are obtained
via a “sandwich estimator.” As the chosen working correlation matrix comes closer to
the truth, we can expect more eﬃcient estimation of the association parameter in βj
in (1). In the setting of genomic data, non-independence working correlation matrices
will generally be closer to the truth for subgroups of data than an independent working
correlation matrix. Note that the ordering of the observations within the subgroup is
meaningful when the working correlation matrix speciﬁes higher correlation between
observations that are placed closer together, as in the case of the AR-1 working correlation matrix. The order of the observations is unimportant when the exchangeable
working correlation matrix is used.
2.2 Applying the Method We next provide a step-by-step description of the
proposed method in application. K represents the total number of SNP loci that are
tested for association with disease, and N is the total number of subjects.
1. For each subject, replicate the case or control status (the value of Y) K times to
create the observations (Yi , Sji ), j = 1 . . . K, i = 1 . . . N.
2. Place the K SNPs into a smaller number of subgroups. Each subgroup of SNPs will
deﬁne a set of observations to be modeled according to (1) and (2) for each subject.
The goal is to place SNPj and SNPk in the same subgroup when it is suspected that
there may be high correlation between Yi −f (αˆj + β̂j Sji ) and Yi −f (αˆk + β̂k Ski ). In

6
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practice, this means that the regression method will be applied to each subgroup
of SNPs as though the SNPs in the subgroup were the only observed SNPs. This
is analogous to the application of a separate logistic regression model for each
SNP, except that now there is a separate GEE application for each subgroup of
SNPs. Note that a SNP may be placed in more than one subgroup, as described
below, if appropriate. For purposes of algorithm convergence, computational speed
and asymptotic validity, subgroups of size 6 to 20 are expected to work well
when the total sample size is 400 or more. In a statistical sense, the goal of
the subgrouping is to obtain test statistics that have little pairwise correlation in
and across subgroups.
(a) Place SNPs in the same subgroup if they are known to be close spatially or
if they are known to be or suspected of being close in function. SNPs in the
same cluster could be:
i. SNPs that are linked so as to result in positive correlation between the
scores at these loci in a random sample of the population (correlation
greater than approximately .10), including SNPs in the same haplotype
block
ii. SNPs in exons for the same gene
iii. SNPs for genes in the same pathway
iv. SNPs in genes encoding proteins that are later spatially linked (as in
anti-body formation)
v. SNPs from genes that are empirically related to the outcome, say, via
segregation analyses or HLA associations
vi. Potential eﬀect modiﬁers such as smoking history; these may be thought
of as “auxiliary SNPs” and placed in the same subgroup with SNPs
whose action they are thought to modify.
(b) a SNP may appear in more than one analytic subgroup, since a given SNP
7
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might be part of more than one functional group.
3. Choose a working correlation structure that is expected to capture at least some of
the true correlation structure in the data. Either “auto-regressive-lag-1” (AR-1) or
“exchangeable” are recommended choices (see appendix), and both are available
in all standard GEE software packages.
4. Choose the “ﬁxed” option for the working correlation matrix. This means that
the parameters for the working correlation matrix are supplied by the user and
not estimated.
5. Organize the data for input to the GEE software. This includes ordering the
observations within a subgroup if not using the exchangeable working correlation
matrix. Also, readying the data for input to the algorithm usually also will include
the creation of an augmented matrix of independent variables in order to generate
separate intercept and regression coeﬃcient estimates (αj and βj ) for each SNPj in
the subgroup. This is necessary if the software is designed only to accomodate the
same variables for every observation. In this case, when no adjustment variables
are included, all but two entries in each row of the augmented independent variable
matrix must be made identically zero, resulting in a matrix with nN rows and 2n
columns. The “no intercept” option should be speciﬁed, since there is no intercept
common to all observations. More details on the creation of this augmented matrix
are given in the Appendix. Finally, the software will require the creation of an ID
vector of length nK that indicates which observations are from the same subject.
6. Apply GEE with the ﬁxed working correlation matrix to each subgroup and obtain
the Wald statistic for each SNP’s coeﬃcient and its corresponding p-value. (The
Wald statistic is the coeﬃcient estimate divided by its standard error, β̂/s.e.(β̂) ≡
GW 1, and the p-value is obtained by comparing this statistic to a standard normal
distribution. Both are provided by any software package).

8
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7. Apply a Bonferroni correction to the K p-values to obtain a correction for multiple
testing.
Comments:
1. SNPs with scores that are negatively correlated in the sample should not be
grouped together, as power loss can obtain in this situation.
2. We have retained the use of the Bonferroni correction to maintain control over
the false positive rate. However, when eﬀective subgrouping is done, the Bonferroni
correction applied to the GEE-based statistics will be less conservative than using this
correction on the set of test statistics obtained by univariate modeling. This happens
because the estimation procedure produces test statistics that are more nearly uncorrelated than does the independence-based estimation procedures.
3. If a SNP appears in more than one subgroup, the user should choose only one test
statistic for that SNP to be the primary test statistic. This test statistic should come
from a subgroup in which the SNP is considered to have a potential main eﬀect. The
SNP may appear in other subgroups as an eﬀect modiﬁer based on known/suspected
function or as an entry akin to a “precision variable” if the SNP score is correlated
(linked) to the SNP(s) of main interest in these other subgroups. The eﬀect of the
“precision variable” is made more clear in the Results.
3. The subgroups may be of diﬀerent sizes.
4. The choice of working correlation matrix can be diﬀerent for diﬀerent subgroups.
5. It is recommended to choose a ﬁxed working correlation matrix in order to speed
the estimation and possibly avoid problems with convergence of the estimation algorithm. This recommendation is facilitated by the fact that specifying high correlation
between observations still provides a power advantage to the GEE method even when
no correlation between SNP scores is present. However, one could choose only the form
of the working correlation matrix and not the actual values if the user ﬁnds this to be
computationally feasible for a given data set.
2.3 Simulation Study of Performance A large simulation study was performed
9
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to evaluate the power of this method to detect an association between disease and an
hypothetic SNP (denoted as SNP1). In each scenario, a score of SNP1=1 confers a
20% elevation in the risk of disease if no eﬀect modiﬁer is present in the subgroup. We
studied the power of the GEE-based method to detect the association between SNP1
and disease when: (A) SNP2 is an eﬀect modiﬁer in the subgroup and does not have
an independent eﬀect on disease; (B) SNP2 is an eﬀect modiﬁer in the subgroup and
also has an independent eﬀect on disease; (C) SNP2 in the subgroup aﬀects disease
risk independenltly of SNP1 but does not modify the eﬀect of SNP1; and (D) none of
the foregoing. In these four scenarios, the proposed method is expected to have power
greater than or equal to the power of the independence-based method. If negative correlation exists between SNP scores in the subgroup, the GEE method can have less
power than the independence-based method. Scenario E was included to illustrate this
situation: (E) SNP2 in the subgroup aﬀects disease risk as in scenario C, while SNP1=1
and SNP2=1 cannot occur simultaneously in the same individual. This produces strong
negative correlation between SNP1 and SNP2 in the case-control sample. This simulates a situation where the co-occurrence is lethal. Rather than simulating data to ﬁt a
convenient mathematical model, we simulated data according to plausible and scientifically interesting biological conditions. The disease probabilities used for each scenario
are given in Table 1.
SNP1 and SNP2 were placed in a subgroup of 12 SNPs such that scores for the SNPs
placed adjacent to each other in the subgroup had that same pairwise correlation, with
decreasing correlation between SNP scores that were farther apart in the subgroup. All
other SNPs in the subgroup had no relationship to disease. An AR-1 working correlation
matrix was used for all simulations. The parameter for the AR-1 matrix, ρ, was ﬁxed
at 0.6, except for the set of simulations that study the eﬀect of varying ρ (see below).
Results were the same for a subsample of simulations re-done with 100 SNPs in the
subgroup (results not shown).
Power was examined for the ﬁve scenarios above when SNP scores were moderately
10
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correlated in the population and when SNPs were uncorrelated in the population. This
provides ten basic simulation scenarios. Additionally, the eﬀect of the working correlation matrix choice was studied by varying the choice of correlation parameter under a
ﬁxed simulation scenario, Scenario B with moderate correlation among SNPs. For this
part of the study, ρ was varied among {0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, .85}. Finally,
the performance of the method in adjusting for population structure was studied by
adding population structure at a third SNP site (SNP3), again under Scenario B with
moderate correlation among SNPs. The simulation data were created in a prospective
manner (i.e. as they would appear in the general population), and then an equal number
of cases and controls was sampled for each simulation study.
The distribution of the genetic scores was generated as follows: The marginal probability that S1=0, P[S1=0], was set to equal 0.5 so that P[S1=0]=P[S1=1]=0.5. This
facilitates the simulation by allowing a subgroup of SNPs with a given mutual pair-wise
correlation structure to be generated non-iteratively. This also maximizes power with
respect to the distribution of the genetic scores, reduing the sample sizes needed and the
sampling/computation time. In preliminary studies, P[S1=1] was set to smaller values
(0.1 and 0.2) with no apparent qualitative eﬀect on the relative powers of the methods
(not shown).
For simulation studies with “moderate” correlation between SNPs, the probability
that S1=1 given S2=1 (P [S1 = 1|S1 = 2]) was set to 0.6, slightly higher than the
overall probability that S1=1. This corresponds to the situation where having the
deleterious polymorphism at site 2 increases the probability of having the deleterious
polymorphism at site 1. This results in a population correlation of 0.20 for the SNP
scores from adjacent SNP sites.
For the ﬁnal study on adjustment for confounding, SNP3 was generated so as to be
confounded by population structure (Balding, 2006) and placed adjacent to SNP1 in the
subgroup. By placing SNP3 adjacent to SNP1 in the subgroup, the confounding eﬀect
at SNP3 is allowed to have the largest impact on estimation of association between
11
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disease and SNP1 when using the AR-1 working correlation matrix. The case-control
sample was simulated such that
1. sub-population 1 has SNP3=1 80% of time, SNP3=0 20% of time
2. sub-population 2 has SNP3=1 20% of time, SNP3=0 80% of time
3. 60% of cases are from sub-population 1, 40% from sub-population 2
4. 32.5% of controls are from sub-population 1, 67.5% from sub-population 2.
This creates an apparent (marginal) odds ratio (OR) of 2.0 for association of SNP3=1
with disease when not adjusted. SNP3 was correlated with SNP1 according to the
design above for the scenarios with moderate correlation between scores at adjacent
SNP loci. To adjust for this confounding, the following (marginal) model was ﬁtted in
lieu of model (1):
Prob[Yi = 1|Sji ] =

exp(αj + βj Sji + βI XIi )
,
1 + exp(αj + βj Sji + βI XIi )

(3)

where XIi is an indicator variable such that XIi = 1 if the ith subject is from population
1 and XIi = 0 if the ith subject is from population 2.
All GEE results are compared to the results from the independence-based logistic
regression method. In addition to the Wald statistic for individual coeﬃcients, the GEE
method allows for joint tests of association by forming a joint Wald statistic using the
estimated covariance among coeﬃcients. For example, the joint signiﬁcance of (β̂1 , β̂2 )
may be tested using


GW 2 = (β̂1 β̂2 )

σ̂11 σ̂12
σ̂12 σ̂11

−1

β̂1
β̂2

(4)

where (β̂1 , β̂2 ) are the estimated coeﬃcients for the eﬀects of SNP1 and SNP2, respectively, σ̂j is the robust estimate of the variance for β̂j , and σ̂jk is the robustly estimated
covariance between β̂j and β̂k . The σ̂’s are obtained from the “working covariance”
matrix returned by the GEE software. A joint test for any set of elements of a subgroup
12

Hosted by The Berkeley Electronic Press

(including the entire subgroup) can be formed in an analogous manner. We report the
power of GW 2 for all simulations as well as for GW 3 deﬁned to be
⎡

⎤−1 ⎛

σ̂jj σ̂j1 σ̂j2
⎢
⎥
GW 3 = (β̂j β̂1 β̂2 ) ⎣ σ̂j1 σ̂11 σ̂12 ⎦
σ̂j2 σ̂12 σ̂22

⎞

β̂j
⎜
⎟
⎝ β̂1 ⎠
β̂2

(5)

In our simulation studies, “SNP3”, corresponding to the regression coeﬃcient β3 above,
is placed adjacent to SNP1 in the subgroup but does not aﬀect disease. The reason
to study this particular GW3 statistic is to determine the loss in power that might be
inﬂicted by adding a coeﬃcient for a truly unassociated SNP site (SNP3) to the joint
test statistic. In the simulations investigating adjustment for confounding, SNP3 in (5)
was spuriously associated with disease through confounding as described above.
The standard practice for investigating the joint eﬀect of two or more variables on
the disease outcome is to include both variables as covariates in a univariate outcome
logistic regression. Speciﬁcally, to investigate the joint eﬀect of SNP1 (S1) and SNP2
(S2) on disease, the following model is usually ﬁtted:
prob[Yi = 1|S1i , S2i ] =

exp(α12 + β1 S1i + β2 S2i )
1 + exp(α12 + β1 S1i + β2 S2i ).

(6)

Hence, GEE results and logistic regression based on model (1) were also compared to
logistic regression results based on model (6). Model (6) is often termed “multivariate
logistic regression” in elementary biostatistics text books, with the “multivariate” aspect
referring to the independent variable rather than the outcome.
To make all results comparable across scenarios, we determined the total number of
SNP sites tested, K, that would result in 50% power for the independence-based logistic
regression method with model (1) after a Bonferroni correction to obtain a family-wise
Type I error rate of 0.05. We then applied this K to all results from a given simulation to
determine the corresponding power for the remaining test statistics. The reported power
for the remaining test statistics is then the proportion of test statistics that are more
extreme than the median (absolute value) of the independece-based test statistics. This
provides a direct comparison of the distributions of two test statistics (a test statistic
13
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with a distribution shifted further from zero than another will provide more power.)
Also, for powers near 50%, the percent increase or reduction in power relative to the
independence-based result is approximately the percent decrease or increase in sample
size, respectively, that one would need to obtain the same power as that attained by the
independence-based method. Five hundred data sets were simulated for each reported
result; sample sizes were 600 cases and 600 controls for Scenarios A-C, and 2000 cases
and 2000 controls for scenarios D-E. Simulations were run using a function written by
the author in the statistical computing language R (www.r-project.org) and may be
obtained by writing the author at emond-at-u.washington.edu.

—
SNP Scores
S1=0 & S2=0
S1=1 & S2=0
S1=0 & S2=1
S1=1 & S2=1

A
0.10
0.10
0.12
0.24

B
0.10
0 .12
0.12
0.24

Scenario
C
D
0.10 0.10
0.12 0.10
0.12 0.12
0.12 0.12

E
0.10
0.12
0.12
NA

Table 1: Probabilities of Disease in Simulation Studies The right portion of the
table shows the simulated probabilities that Y=1 (disease is present) in the population
for the four possible conﬁgurations of genetic scores at SNP locus 1 (S1) and at SNP
locus 2 (S2)(left portion of the table).
Results Results are summarized in Tables 2 and 3. In Scenarios A and B, the
GEE-based test statistic GW 1 = β̂1G /se(β̂1G ) achieved 35% greater power than the
corresponding statistic from independence-based logistic regression, L1 = β̂1L /se(β̂1L ),
when modest correlation was present between SNP scores in the population. (The
superscripts G and L have been added to make clear that the estimates are obtained
from the diﬀerent estimation procedures.) In these two scenarios, SNP2 was an eﬀect
modiﬁer for SNP1 as described in Table 1. In scenario C, the eﬀects of the deleterious
SNP scores are not synergistic as they are in scenarios A and B, but the GW1 statistic
still has 8.4% greater power to detect the assocation between SNP1 and diseas as long
as correlation is present between SNP1 and SNP2 in the population. There was no
power gain in scenario C when no correlation is present between SNP1 and SNP2. In
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scenario D, where SNPs is completely unrelated to disease, there was no appreciable
power gain for GW1 rleative to L1 in scenario D for either SNP correlation structure.
The statistic ML from independence-based logistic regression using model (6) to
account for the aﬀect of SNP2 performed very poorly relative to L1 except in the cases
where no positive correlation between SNP scores was induced in the sample (scenarios
C and D with no correlation between SNPs in the population).

Risk
Scenario
A
B
C
D
E
A
B
C
D
E
B
B
B
B
B
B
B
B
B
B

pop.
cor(S1, S2)
0.20
0.20
0.20
0.20
0.20
0.00
0.00
0.00
0.00
0.00
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20

sample
cor(S1, S2)
0.27
0.26
0.18
0.20
-0.42
0.08
0.06
-0.02
0.00
-0.52
0.26
0.26
0.26
0.26
0.26
0.26
0.26
0.26
0.26
0.26

AR-1
ρ
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.85

L1
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0
50.0

Power (%)
Test Statistic
GW1 GW2 GW3
67.4
81.0
78.2
67.4
91.0
89.2
54.2
73.2
75.2
51.2
48.4
46.4
36.0
91.8
93.0
57.4
85.0
79.8
54.2
93.8
93.2
49.2
78.8
84.2
50.6
47.6
44.2
30.2
96.4
95.6
50.0
91.4
89.4
54.6
91.4
89.6
59.4
91.4
89.8
62.8
91.4
89.8
65.0
91.4
89.6
66.6
91.0
89.4
67.4
91.0
89.2
67.6
91.0
89.0
66.8
91.0
88.8
66.8
90.6
88.8

ML
11.2
8.6
37.2
46.4
81.8
40.4
37.4
51.6
50.6
87.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6

Table 2: Simulation Results The power to detect the association between disease
and a genetic score of 1 at SNP locus 1 is given in the right portion of the table
for 5 test statistics and the 5 disease probability scenarios described in the Methods.
L1 = β̂1 /se(β̂1 ) from the independence-based logistic regression method using model (1);
GW 1 = β̂1 /se(β̂1 ) from GEE using (1) as the (marginal) model; GW2 and GW3 are joint
test statistics given by equations (4) and (5); and M L = β̂1 /se(β̂1 ) from independencebased logistic regression using model (6); pop. cor(S1, S2) is the correlation between
scores at loci 1 and 2 in the population; sample cor(S1, S2) is the correlation between
socres at loci 1 and 2 in the case-control sample; ρ is the ﬁxed value used in the AR-1
working correlation matrix.
The joint test of assocation between disease and SNPs 1 and 2 (given by GW2,
Table 2) performed very well except in scenario D where SNP2 was not associated with
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disease in any way (neither as an eﬀect modiﬁer alone nor via a main eﬀect). GW3 was
always less powerful than GW2, except in scenario C.
When the AR-1 working correlation parameter for the GEE method varied from 0
to 0.85 in scenario B, the greatest power was attained when ρ = 0.70. This optimal
value of ρ is related to both cor(S1, S2) and the combined eﬀects of SNP1 and SNP2
on disease. The power for GW 2 and GW 3 did not change appreciably as ρ varied.
When ρ = 0, the GEE method reduces to the independence-based method. Note that
no power is lost (relative to the independence method) by assuming ρ = 0.6, even in
the scenario where SNP2 is unrelated to disease and SNPs are uncorrelated (Table 2,
row 9).
For the case when confounding through population structure was present to give
SNP3 an apparent assocation with disease (Table 3), the power for both L1 and GW1
was increased relative to the results when no confouding was present (Table 2). This
is because the score at SNP1 is correlated with the score at SNP3, resulting in some
degree of confounding of the association between disease and SNP1. After adjustment
for confounding, GW1 still attains a 34% increase in power relative to L1, though the
power is reduced relative to the unconfounded, unadjusted case in Table 2.

Adjusted
Fit
no
yes

sample
cor(S1, S3)
0.22
0.22

sample
cor(S1, XI )
0.16
0.16

L1
85.6
38.6

GW1
97.6
55.8

Power (%)
Test Statistic
SNP1
GW2 GW3 ML
99.4
100
37.4
85.8
82.8
7.0

SNP3
L1 GW1
79.2
85.6
0
0

Table 3: Confounding Simulation Results The right portion of the table shows
powers for test statistics when the relationship between the SNP3 score (S3) and disease
is confounded by population structure. SNP3 is placed adjacent to SNP1 in the subgroup
under disease scenario B with moderate correlation between SNPs, as described in the
Methods. The unadjusted results are obtained by ﬁtting (marginal) model (1) for either
independence-based logistic regression or GEE to obtain the test statistics L1, GW1,
GW2, GW3 and ML as described in Table 2. Adjusted results are obtained analogously
by ﬁtting (marginal) model (3) for each SNP in the subgroup. Powers for all ﬁve test
statistics are given for the tests of association involving SNP1 either singly or jointly;
powers are given for testing association between disease and SNP3 singly.
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In the case where SNP1 and SNP2 had strong negative correlation in the sample
(scenario E), GW1 performed poorly. The relative descrease in power for GW1 is less
when the magnitude of the negative correlation is less.
Theoretical results by Gourieroux et al (1984) show that test sizes should be at the
nominal levels. As a check, we computed test sizes on data simulated under the global
null hypothesis. All test sizes were between 0.02 and 0.04.
Discussion The method proposed here provides power gains that have practical
potential to provide better discovery of associations between subject status and risk
factors measured via high throughput gene-based assays. The method is easy to apply,
and GEE-derived tests are known to have good behavior, at least when the subgroup size
is small relative to the sample size ( 1:20 ratio or less). Examination of formulas for the
variance of GEE-based parameter estimates in multivariate models indicates that the
proposed power boosting method can be expected to have greater power when SNPs
in the same subgroup either have positive sample correlation between scores and/or
increase the probability of disease. The exception to this rule is the situation where cooccurrence of the deleterious SNP scores is reduced enough among cases that negative
correlation is induced between SNP scores as in simulation scenario D. Placing SNPs
with negatively correlated scores in the same subgroup can potentially reduce power.
A suggested use for this method is to base the sample size calculations on considerations such as those discussed in Prentice and QI (2006), where it is assumed that an
independece-based analysis will be done. The multivariate analysis can then be substituted for the former for potential power gains. It might be tempting to try to use
this method to reduce the sample size needed to obtain a speciﬁed power. However,
we don’t currently recommended this as a general strategy. One reason to avoid this
strategy is that the nature of this method makes analytic power formulas intractable
at this point in time. Hence, one must resort to simulation studies to estimate power.
While simulations were used by Prentice and QI (2006) to estimate power, it is much
easier to specify the magnitude of a biologically interesting marginal odds ratio in a
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simulation than it is to specify the underlying sample correlation structure of the chosen subgroups. In cases where the joint distribution of interesting SNP scores is known,
power simulations for this multivariate method could be done.
While we believe it is of interest to report our power results for GW2 and GW3 , the
(markedly) superior performance of these statistics is limited to the situation where at
least two of the SNP loci in the joint test are associated with disease. Hence, in order
for a joint test to be superior to GW1, one would need to be reasonably sure in advance
that the majority of SNPs involved in the joint test are truly associated with disease
– a rather unlikely scenario. A possible use for these statistics is for joint testing of
very tightly linked SNPs, rather than discarding some of these tightly linked SNPs to
provide a “tag” SNP set for testing. This suggestion needs further research, however.
A nice feature of this method is that it provides extra power to detect a main effect when eﬀect modiﬁers are included in the subgroup. In this sense, including eﬀect
modiﬁers in a subgroup is analogous to including “precision variables” in a linear regression model. This feature could also help elucidate the eﬀect modiﬁers. With the
independence-based method, one would need to add many more tests in the form of
additional test coeﬃcents from a model that includes interaction terms to identify effect modiﬁcation (epistasis), with a possibly dramatic reduction in power. Power loss
would occur for two reasons: due to a substantial increase in the multiplicity of tests
performed and due to lower power attained when using models with multiple correlated
covariates. The latter is the well-known problem of “collinearity.” In addition, it is
infeasible to model all potentially synergistic combinations of SNPs. The method proposed here could help narrow the candidate ﬁeld in a search for eﬀect modiﬁcation: one
could identify signiﬁcant genes from a testing phase using model (1), and then perform
additional tests for potential eﬀect modiﬁcation by other SNPs in the same subgroup
as the candidate SNP. One could allow for a relatively small number of new tests to
be performed in this second phase when planning the multiple testing corrections that
should be taken into account in the Bonferroni correction.
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We have shown that the suggested subgrouping can result in increased power in
biologically interesting scenarios. Admittedly, subgrouping based on considering every
the location and/or possible functional implications for every SNP locus in the study
would be impractical to apply. However, it is quite worthwhile to apply the subgrouping
in a careful manner just for those SNPs for which the investigator has some a priori
knowledge or suspicion of relationship to each other, either spatially or functionally.
This is especially true when these SNPs are considered most likely a priori to have an
association with disease. Placing SNPs in the same subgroup when they act independently on disease risk (i.e. no interaction/epistasis eﬀects) will also increase power in a
case-control design. Functional groups of genes have been published that can make the
task easier when the investigator’s loci can be matched to genes within these groups
(Subramania et al., 2005). For other SNPs, one can subgroup based solely on location.
Alternatively, SNPs that cannot be placed into a natural subgroup in via a practical
procedure can be grouped randomly. It is worth re-iterating that SNPs with negatively
correlated scores should not be placed in the same subgroup, since this can result in
power losses. SNPs of known interest could be screened for negative correlation prior
to the subgrouping. The risk of including negatively correlated SNP scores in the same
subgroup by accident is probably quite low, and the impact would only be meaningful
if these SNPs were associated with disease.
The reader may have noted that model (1) does not specify the true relationship
between the outcome and the covariates of interest for any of the Scenarios except D.
When using GEE it is usually considered important to correctly specify the model for
the mean. For a logistic model, the mean is the formula for Prob[Y = 1]. Correct
mean speciﬁcation is not needed here where we are interested in the test statistics
β̂/s.e.(β̂) and not explicitly interested in correct estimation of β̂. In a one-stage study,
the independence-based logistic regression technique will provide unbiased estimates
of the marginal eﬀect of SNP1 (that is the average eﬀect of SNP1, averaging over
the eﬀects of all other SNPs), while GEE-based estimates using a non-independence
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working covariance matrix do not (Pepe and Anderson, 1994; Emond et al, 1997).
Hence, the proposed procedure is not intended for estimation, only testing. If the
estimates themselves are of interest, these can be obtained via independence-based
logistic regression after the testing step is completed. In general, one cannot hope to
specify the correct relationship between probability of disease and all SNP sites that
might aﬀect risk.
The proposed method performs well relative to the independence-based procedure
for removing confounding eﬀects. However, when adjustment variables are correlated
with the variables of interest, adding these adjustment variables to the model reduces the
power to detect true eﬀects relative to omitting them. Hence, we suggest that potential
confounding be investigated after signiﬁcant associations have been identiﬁed using the
non-adjusted model (1) in a testing phase. This would be akin to identifying patients
who meet inclusion criteria for a study and then assessing for speciﬁc exclusion criteria
in a second step. This procedure provides more power for ﬁnding true associations than
simultaneous testing and adjustment using model (3).
Use of multivariate modeling for power boosting is not limited to whole genome
SNP-disease association studies. The method can be applied to numerous kinds of multiple outcome data types, including those that result from the multiplicity of genes in an
organism. As a second example, consider the case of a two-sample paired RNA microarray expression study, where RNA samples from diseased and non-diseased subjects are
competitively hybridized on the same array to obtain expression ratios for thousands of
genes. Let Yij denote the log expression ratio for the ith pair and the j th oligonucleotide.
It is common to use a paired t-test to obtain a p-value for the test of no diﬀerence in
expression for every outcome. This is equivalent to testing αj = 0 in the simple model
Yij = αj , a regression model with only an intercept term. The multivariate power boosting method can be applied here by subgrouping oligonucleotides and applying GEE to
the subgroups. A coeﬃcient must be estimated for each oligonucleotide in the subgroup,
which usually will require the use of dummy variables in the design matrix as in the
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main example. Note the that sampling method in this “two-sample” experiment is a
case-control design as in our main example, so analogous considerations hold.
A few methods have been proposed for potentially increasing the power over the Bonferroni method in genome-wide studies. These include the truncated product method
for combining p-values when the test statistics are uncorrelated (Zaykin, et al, 2002),
resampling (Reiner et al, 2003; Pollard and van der Laan, 2005), and estimation of analytic distributions for combined evidence (Dudbridge and Koeleman, 2004). In addition,
a new approach for deﬁning signiﬁcance in the multiple testing situation is proposed
by Storey (2006). Each of these methods is a “post-processing” method for the test
statistics or p-values and any can be applied in addition to multivariate power boosting
when their conditions are met. Among the methods listed, resampling is the most studied. Resampling provides potentially more power by preserving the correlation structure
within individuals during the resampling process. This is similar in principle to multivariate power boosting, and it is not clear whether much is to be gained by applying
both methods. The operating characteristics of combined methods is a topic for further
study.
In summary, the proposed method of employing multivariate modeling with robust
estimation is a relatively easy method for increasing statistical power in high-throughput
studies if eﬀective subgrouping can be done. The method can be implemented using
readily available software.
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Appendix A.1 Working correlation matrix forms The AR-1 working correlation matrix has the form:
⎡
⎢
⎢
⎢
R=⎢
⎢
⎢
⎣

ρ2
ρ
1

ρ
1
ρ

1
ρ
ρ2
..
.

· · · ρn−1
· · · ρn−2
· · · ρn−3
..
.

ρn−1 ρn−2 ρn−3 · · ·

⎤
⎥
⎥
⎥
⎥
⎥
⎥
⎦

1

The exchangeable working correlation matrix has the form:
⎡
⎢
⎢
⎢
R=⎢
⎢
⎢
⎣

⎤

1 ρ ρ ··· ρ
ρ 1 ρ ··· ρ ⎥
⎥
⎥
ρ ρ 1 ··· ρ ⎥
..
.. ⎥
⎥
.
. ⎦
ρ ρ ρ ··· 1

When using the “ﬁxed” working correlation matrix option with GEE software, the user
will usually need to supply an actual matrix with numerical values. Otherwise, the
parameter ρ (and other parameters, if applicable for other forms of working correlation
matrix) will be estimated by the software procedure. The user should consult the manual
for details speciﬁc to the software.
A.2 Creating the matrix of independent variables GEE software generally
assumes that the coeﬃcients to be estimated are common to all elements of the subgroup.
This is not the case for this approach. Hence, in order to estimate the unique intercept
and coeﬃcient term for each SNP locus (αj and βj , respectively), dummy variables must
be added to the independent variable matrix. For a subgroup with n elements (loci),
this matrix will have 2n columns corresponding to the n sets of (αj , βj )s. Suppose we
number the elements of the subgroup from 1 to n. To reformulate the model in terms of
covariates that are common to all elements of the subgroup, the linear predictor term
in (1) can be re-written as
α1 + β1 S1i + α2 + β2 S2i + α3 + β3 S3i + . . . + αj + βj Sji + · · · + αn + βn Sni ,
where all Sjs are identically zero except for Sji . The independent variable matrix
will have nN rows corresponding to the n observations from each of N subjects. For
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example, if n = 3, the 3 rows of the independent variable matrix for the ith subject will
be

1 S1i 0 0 0 0
0 0 1 S2i 0 0
0 0 0 0 1 S3i

where the actual observed values are substituted in place of the Sj’s. If adjustment variables (potential confounding variables) are ﬁtted, an additional column will be included
for each adjustment variable.
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